Table_1_Neutrophil Extracellular Traps in SARS-CoV2 Related Pneumonia in ICU Patients: The NETCOV2 Study.DOCX
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a poorly understood disease involving a high inflammatory status. Neutrophil extracellular traps (NETs) have been described as a new pathway to contain infectious diseases but can also participate in the imbalance of the inflammatory and the coagulation systems. NETs could be a therapeutic target in COVID-19 patients.
Methods: Consecutive patients with SARS-CoV2 related pneumonia admitted to the intensive care unit were included in a prospective bicentric study. Neutrophil extracellular trap concentrations were quantified in whole blood samples at day-1 and day-3 by flow cytometry. The primary outcome was the association between the blood NET quantification at ICU admission and the number of days with refractory hypoxemia defined by a PaO2/FIO2 ratio ≤100 mmHg.
Results: Among 181 patients admitted to the ICUs for acute respiratory failure related to SARS-CoV2 pneumonia, 58 were included in the analysis. Patients were 62 [54, 69] years old in median, mostly male (75.9%). The median number of days with severe hypoxemia was 4 [2, 6] days and day-28 mortality was 27.6% (n = 16). The blood level of NETs significantly decreased between day-1 and day-3 in patients who survived (59.5 [30.5, 116.6] to 47 [33.2, 62.4] p = 0.006; 8.6 [3.4, 18.0] to 4 [1.4, 10.7] p = 0.001 and 7.4 [4.0, 16.7] to 2.6 [1.0, 8.3] p = 0.001 for MPO+, Cit-H3+, and MPO+ Cit-H3+ NETs, respectively) while it remained stable in patients who died (38.4 [26.0, 54.8] to 44.5 [36.4, 77.7] p = 0.542; 4.9 [1.3, 13.0] to 5.5 [2.8, 6.9] p = 0.839 and 4 [1.3, 13.6] to 2.7 [1.4, 4.5] p = 0.421 for MPO+, Cit-H3+, and MPO+ Cit-H3+ NETs, respectively). In multivariable negative binomial regression, the blood level of MPO+ NETs was negatively associated with the number of days with severe hypoxemia within 7 days (0.84 [0.73, 0.97]), while neither Cit-H3+ NETs nor double-positive NETs were significantly associated with the primary outcome.
Conclusion: The whole blood level of NETs at day-1 was negatively associated with the number of days with severe hypoxemia in patients admitted to the intensive care unit for SARS-CoV2 related pneumonia. The lack of decrease of the blood level of NETs between day-1 and day-3 discriminated patients who died within day-28.
History
References
- https://doi.org//10.1126/science.1092385
- https://doi.org//10.1083/jcb.200606027
- https://doi.org//10.1083/jcb.200806072
- https://doi.org//10.1161/ATVBAHA.111.242859
- https://doi.org//10.3389/fimmu.2016.00236
- https://doi.org//10.1056/NEJMra1208623
- https://doi.org//10.1172/jci.insight.98178
- https://doi.org//10.1097/ALN.0000000000002619
- https://doi.org//10.1183/13993003.01389-2017
- https://doi.org//10.1186/s13054-018-2290-8
- https://doi.org//10.3389/fimmu.2013.00056
- https://doi.org//10.1016/j.ajpath.2011.03.013
- https://doi.org//10.1016/j.ajpath.2017.09.014
- https://doi.org//10.1146/annurev-pathol-011110-130158
- https://doi.org//10.18632/oncotarget.22744
- https://doi.org//10.1016/S0140-6736(20)30566-3
- https://doi.org//10.1001/jama.2020.6775
- https://doi.org//10.1016/S0140-6736(20)30628-0
- https://doi.org//10.1084/jem.20200652
- https://doi.org//10.1093/cid/ciaa248
- https://doi.org//10.1001/jamainternmed.2020.0994
- https://doi.org//10.1056/NEJMoa2015432
- https://doi.org//10.1016/S2213-2600(20)30243-5
- https://doi.org//10.1016/S1473-3099(20)30086-4
- https://doi.org//10.1001/jama.2012.5669
- https://doi.org//10.1001/jama.270.24.2957
- https://doi.org//10.1007/BF01709751
- https://doi.org//10.1186/s13054-019-2663-7
- https://doi.org//10.1007/s00134-018-5172-2
- https://doi.org//10.1378/chest.111.1.209
- https://doi.org//10.1002/ajh.24185
- https://doi.org//10.1002/cyto.a.23169
- https://doi.org//10.2307/2333011
- https://doi.org//10.1093/infdis/jix475
- https://doi.org//10.3389/fimmu.2016.00518
- https://doi.org//10.1038/s41598-018-29659-1
- https://doi.org//10.1182/blood.2020007008
- https://doi.org//10.1126/science.abc6027
- https://doi.org//10.1074/jbc.M405883200
- https://doi.org//10.4049/jimmunol.1201719
- https://doi.org//10.1007/s00134-020-06062-x
- https://doi.org//10.1016/j.amjcard.2020.06.007
- https://doi.org//10.1111/j.1538-7836.2011.04544.x
- https://doi.org//10.1073/pnas.1005743107
- https://doi.org//10.1182/blood-2016-06-722298
- https://doi.org//10.1182/blood-2017-01-757328
Usage metrics
Read the peer-reviewed publication
Categories
- Radiology and Organ Imaging
- Foetal Development and Medicine
- Obstetrics and Gynaecology
- Medical Genetics (excl. Cancer Genetics)
- Medical and Health Sciences not elsewhere classified
- Dermatology
- Emergency Medicine
- Gastroenterology and Hepatology
- Geriatrics and Gerontology
- Intensive Care
- Primary Health Care
- Nephrology and Urology
- Nuclear Medicine
- Orthopaedics
- Otorhinolaryngology
- Pathology (excl. Oral Pathology)
- Family Care